{"id":"https://openalex.org/W2150143181","doi":"https://doi.org/10.1111/bju.12717","title":"Quantification of skeletal metastases in castrate\u2010resistant prostate cancer predicts progression\u2010free and overall survival","display_name":"Quantification of skeletal metastases in castrate\u2010resistant prostate cancer predicts progression\u2010free and overall survival","publication_year":2014,"publication_date":"2014-03-03","ids":{"openalex":"https://openalex.org/W2150143181","doi":"https://doi.org/10.1111/bju.12717","mag":"2150143181","pmid":"https://pubmed.ncbi.nlm.nih.gov/24589330"},"language":"en","primary_location":{"id":"doi:10.1111/bju.12717","doi":"https://doi.org/10.1111/bju.12717","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bju.12717","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://research.manchester.ac.uk/en/publications/65dfbd98-1846-40c9-9dda-6d38de5283d7","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006377758","display_name":"Campbell D. Tait","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Campbell Tait","raw_affiliation_strings":["Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK","Department of Urology, The Christie NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]},{"raw_affiliation_string":"Department of Urology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David Moore","raw_affiliation_strings":["Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088587509","display_name":"Clare Hodgson","orcid":"https://orcid.org/0000-0001-5124-1216","observed_orcids":["https://orcid.org/0000-0001-5124-1216"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Clare Hodgson","raw_affiliation_strings":["Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089777135","display_name":"Mick D. Brown","orcid":"https://orcid.org/0000-0003-1322-4671","observed_orcids":["https://orcid.org/0000-0003-1322-4671","https://orcid.org/0000-0002-0370-8077"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Brown","raw_affiliation_strings":["The Genito Urinary Cancer Research Group, Institute of Cancer Sciences, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Genito Urinary Cancer Research Group, Institute of Cancer Sciences, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058225499","display_name":"Thomas Morris","orcid":"https://orcid.org/0000-0003-4957-5625","observed_orcids":["https://orcid.org/0000-0003-4957-5625"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Morris","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109164243","display_name":"Jim Growcott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jim Growcott","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111699613","display_name":"Michael D. Malone","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael Malone","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049602345","display_name":"Andrew M. Hughes","orcid":"https://orcid.org/0000-0002-8690-4056","observed_orcids":["https://orcid.org/0000-0002-8690-4056"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Hughes","raw_affiliation_strings":["AstraZeneca, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005543131","display_name":"Andrew G. Renehan","orcid":"https://orcid.org/0000-0002-9115-4405","observed_orcids":["https://orcid.org/0000-0002-9115-4405","https://orcid.org/0000-0003-4309-4396"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Renehan","raw_affiliation_strings":["Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065195021","display_name":"Noel William Clarke","orcid":"https://orcid.org/0000-0001-7776-8059","observed_orcids":["https://orcid.org/0000-0001-7776-8059"]},"institutions":[{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210111611","display_name":"Salford Royal Hospital","ror":"https://ror.org/027rkpb34","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111611","https://openalex.org/I4405259061"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Noel W. Clarke","raw_affiliation_strings":["Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK","Department of Urology, The Christie NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Salford Royal NHS Foundation Trust, Salford, UK","institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611"]},{"raw_affiliation_string":"Department of Urology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039337111","display_name":"Caroline Dive","orcid":"https://orcid.org/0000-0002-1726-8850","observed_orcids":["https://orcid.org/0000-0002-1726-8850"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Caroline Dive","raw_affiliation_strings":["Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5065195021"],"corresponding_institution_ids":["https://openalex.org/I2801120809","https://openalex.org/I4210111611","https://openalex.org/I4210131968","https://openalex.org/I4210133995"],"apc_list":{"value":4770,"currency":"USD","value_usd":4770},"apc_paid":null,"fwci":2.5283,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.89736189,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"114","issue":"6b","first_page":"E70","last_page":"E73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.03319999948143959,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12108","display_name":"Management of metastatic bone disease","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.8999999761581421},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.9190000295639038},{"id":"https://openalex.org/keywords/disease-stratification","display_name":"disease stratification","score":0.6859999895095825},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9340000152587891},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/bone-scintigraphy","display_name":"bone scintigraphy","score":0.7789999842643738},{"id":"https://openalex.org/keywords/prognosis","display_name":"prognosis","score":0.33899998664855957}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9648157954216003},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7470940947532654},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6982723474502563},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.664081335067749},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6633212566375732},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5678680539131165},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5468329191207886},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5258967280387878},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4771261215209961},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4653834402561188},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.42832356691360474},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.38228487968444824},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.37585633993148804}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011877","descriptor_name":"Radionuclide Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D064129","descriptor_name":"Prostatic Neoplasms, Castration-Resistant","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/bju.12717","doi":"https://doi.org/10.1111/bju.12717","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bju.12717","pdf_url":null,"source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},{"id":"pmid:24589330","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24589330","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU international","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire/65dfbd98-1846-40c9-9dda-6d38de5283d7","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/65dfbd98-1846-40c9-9dda-6d38de5283d7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tait, C, Moore, D, Hodgson, C, Brown, M, Morris, T, Growcott, J, Malone, M, Hughes, A, Renehan, A, Clarke, N W & Dive, C 2014, 'Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival', BJU international, vol. 114, no. 6b. https://doi.org/10.1111/bju.12717","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pure.atira.dk:openaire/65dfbd98-1846-40c9-9dda-6d38de5283d7","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/65dfbd98-1846-40c9-9dda-6d38de5283d7","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tait, C, Moore, D, Hodgson, C, Brown, M, Morris, T, Growcott, J, Malone, M, Hughes, A, Renehan, A, Clarke, N W & Dive, C 2014, 'Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival', BJU international, vol. 114, no. 6b. https://doi.org/10.1111/bju.12717","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W564441098","https://openalex.org/W1779980472","https://openalex.org/W1975577875","https://openalex.org/W1981630080","https://openalex.org/W2008522603","https://openalex.org/W2012815184","https://openalex.org/W2024548912","https://openalex.org/W2058825665","https://openalex.org/W2066845679","https://openalex.org/W2080041465","https://openalex.org/W2096001110","https://openalex.org/W2103959341","https://openalex.org/W2110707581","https://openalex.org/W2122904975","https://openalex.org/W2123526148","https://openalex.org/W2134697866","https://openalex.org/W2148643283","https://openalex.org/W2149752186","https://openalex.org/W2152526126","https://openalex.org/W2152974973","https://openalex.org/W2159044597","https://openalex.org/W2160042168","https://openalex.org/W2167331614","https://openalex.org/W2168108459","https://openalex.org/W2169258216","https://openalex.org/W2411816334"],"related_works":["https://openalex.org/W4403997810","https://openalex.org/W3101707942","https://openalex.org/W2556084841","https://openalex.org/W2404852579","https://openalex.org/W2995594073","https://openalex.org/W2597962758","https://openalex.org/W3088500274","https://openalex.org/W1943084950","https://openalex.org/W7202201096","https://openalex.org/W2790123857"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"report":[2],"a":[3,73,78,201,204,208],"simplified":[4],"and":[5,20,66,81,103,113,123,131,147,159,177,203,213,222,235],"effective":[6],"method":[7,218],"for":[8,133],"substratification":[9],"of":[10,27,63],"M1":[11,38],"castrate-resistant":[12],"prostate":[13],"cancer":[14],"(CRPC)":[15],"by":[16,49],"correlating":[17],"progression-free":[18],"(PFS)":[19],"overall":[21],"survival":[22],"(OS)":[23],"with":[24,37,56,72,96,107,135,157,190,194],"simple":[25,217],"quantification":[26],"skeletal":[28,198],"metastases.":[29,109],"PATIENTS":[30],"AND":[31],"METHODS:":[32],"In":[33],"all,":[34],"561":[35],"men":[36],"CRPC":[39,191],"were":[40,138],"studied":[41],"longitudinally.":[42],"Individual":[43],"bone":[44,51],"scan":[45],"disease":[46,220],"burden,":[47],"quantified":[48],"counting":[50],"metastasis":[52,75],"number,":[53],"was":[54,118],"correlated":[55],"clinical":[57],"outcome":[58],"using":[59],"specific":[60],"threshold":[61],"points":[62],"1-4,":[64],"5-20":[65,108],">20":[67,136],"detectable":[68],"lesions.":[69],"RESULTS:":[70],"Patients":[71,95],"higher":[74],"number":[76],"had":[77,99,165],"shorter":[79,139],"PFS":[80,102,112,130,168],"OS":[82,104,114,132,178],"(hazard":[83],"ratio":[84],"[HR]":[85],"2.0,":[86],"95%":[87],"confidence":[88],"interval":[89],"[CI]":[90],"1.7-2.4;":[91],"P":[92,174,184],"<":[93,175,185],"0.001).":[94],"1-4":[97,158,195],"metastases":[98,137,199],"much":[100],"better":[101,202],"than":[105],"those":[106],"The":[110],"median":[111],"in":[115,207],"the":[116,162],"latter":[117,163],"10.9":[119],"(95%":[120,125,143,149,170,180],"CI":[121,144,150,171,181],"8.4-12.8)":[122],"22.1":[124],"CI:":[126],"18.5-24.5)":[127],"months,":[128,152],"respectively.":[129],"patients":[134,189,229],"still":[140],"[median":[141],"5.3":[142],"3.4-6.9)":[145],"months":[146],"13.3":[148],"11.3-17.6)":[151],"respectively].":[153],"Dichotomising":[154,188],"into":[155,192],"cohorts":[156,193],"\u22655":[160,197],"metastases,":[161],"group":[164],"considerably":[166],"poorer":[167],"[8.4":[169],"6.8-10.3)":[172],"months;":[173,183],"0.001)":[176],"[18.7":[179],"17.5-22.1)":[182],"0.001].":[186],"CONCLUSIONS:":[187],"or":[196],"identifies":[200],"worse":[205],"cohort":[206],"manner":[209],"that":[210],"is":[211],"easy":[212],"clinically":[214],"accessible.":[215],"This":[216],"facilitates":[219],"stratification":[221],"patient":[223],"management,":[224],"enabling":[225],"clinicians":[226],"to":[227,236],"counsel":[228],"more":[230,241],"effectively":[231],"about":[232],"long-term":[233],"outcomes":[234],"help":[237],"select":[238],"intervention":[239],"therapies":[240],"effectively.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}